A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ENSG00000006468.9 | ETS variant transcription factor 1 | |
ENSG00000105722.5 | ETS2 repressor factor | |
ENSG00000163497.2 | FEV transcription factor, ETS family member | |
ENSG00000120690.9 | E74 like ETS transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ERF | hg19_v2_chr19_-_42759300_42759324 | 0.94 | 4.7e-03 | Click! |
ELF1 | hg19_v2_chr13_-_41593425_41593480 | -0.88 | 2.0e-02 | Click! |
ETV1 | hg19_v2_chr7_-_14028488_14028516 | -0.59 | 2.2e-01 | Click! |
FEV | hg19_v2_chr2_-_219850277_219850379 | 0.39 | 4.4e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.0 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 3.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 3.0 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 2.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 2.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 2.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.8 | 2.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.4 | 2.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 2.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 2.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 5.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 4.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 3.7 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 2.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 1.7 | GO:0071817 | MMXD complex(GO:0071817) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 5.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 4.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.8 | 2.3 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 2.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 2.0 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.4 | 1.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 3.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 2.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 2.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 2.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 2.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 2.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 2.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |